Results 171 to 180 of about 109,296 (278)

Evaluation of Dose Distributions From Elongated and Curved Brachytherapy Sources Using Conventional Treatment Planning Software and Monte Carlo Methods [PDF]

, 2011
Elizabeth Bannon, Mark J. Rivard
openalex   +1 more source

Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis [PDF]

, 2018
Badiyan, Shahed, Gay, Hiram A, Markovina, Stephanie, Meeks, Marshall W, Michalski, Jeff, Paradis, Alethea, Sandhu, Gurdarshan, Vetter, Joel   +7 more
core   +2 more sources

Morphological variation in rectal hydrogel spacer one month after insertion during low-dose-rate brachytherapy for prostate adenocarcinoma. [PDF]

Radiat Oncol J
Choi H, Lee SJ, Park Y, Kim W, Lee H, Cho J.   +5 more
europepmc   +1 more source

Integration of external beam and low dose rate brachytherapy in prostate cancer treatment [PDF]

, 2001
V. Narayana, Patrick W. McLaughlin, V. Marable, Brett Miller, D.D. Drake, R.J. Winfield, Peter L. Roberson   +6 more
openalex   +1 more source

SP-0235: Facial growth and developmental outcomes following pediatric head and neck brachytherapy

, 2018
M. Hol, Bradley R. Pieters
openalex   +1 more source

Successful Interstitial HDR Brachytherapy for Nasal Skin SCC in Xeroderma Pigmentosum: An Eight-Year Follow-Up Case Report. [PDF]

Clin Case Rep
Saraei P, Derakhshandeh V, Bagheri A.
europepmc   +1 more source

Prostate Brachytherapy: Advancing Prostate Cancer Treatment in the Region

Nadeem Pervez, Saad Alrashidi
openalex   +2 more sources

Prostate‐specific antigen nadir within 12 months as an early surrogate marker of biochemical failure and distant metastasis after low‐dose‐rate brachytherapy or external beam radiotherapy for localized prostate cancer

, 2018
Shuichi Nishimura, Toshio Ohashi, Tetsuo Momma, M Sakayori, Takahisa Eriguchi, Tomoki Tanaka, Shoji Yamashita, Takeo Kosaka, Mototsugu Oya, Naoyuki Shigematsu   +9 more
openalex   +1 more source

Functional outcomes and toxicity following focal low-dose-rate brachytherapy for low-intermediate risk prostate cancer. [PDF]

BJUI Compass
Adhami M, Cheng J, Anderson E, Smyth L, Davey C, Nguyen T, O'Sullivan R, Ryan A, Lawrentschuk N, Grummet J, See A.   +10 more
europepmc   +1 more source

Balancing Efficacy and Toxicity in Salvage Brachytherapy and SBRT for Radio-Recurrent Prostate Cancer: Insights Beyond the UroGEC Review. [PDF]

Technol Cancer Res Treat
Bilski M, Fijuth J, Kuncman Ł.
europepmc   +1 more source